Brachytherapy

Combined brachytherapy techniques should be benchmark for cervical cancer treatment

An investigation on the late side effects of a combination of two forms of brachytherapy to treat cervical cancer has revealed that the technique delivers higher radiation doses to the tumor without additional treatment-related complications afterwards.

Brachytherapy improves survival for inoperable early stage endometrial cancer

By

Brachytherapy, with or without external beam radiation, can improve survival in women with inoperable, early stage endometrial cancer.

High-dose rate brachytherapy: From adjuvant therapy to an alternative for prostate cancer

High-dose rate brachytherapy: From adjuvant therapy to an alternative for prostate cancer

By

High-dose-rate (HDR) brachytherapy is typically used as a dose-escalating boost for external beam radiotherapy for prostate cancer; however, some researchers believe it might be close to graduating to a viable monotherapy.

Optimizing quality and safety of high dose-rate brachytherapy

By

Specific guidance for delivering high dose-rate brachytherapy to improve quality and safety is offered in a new white paper from the American Society for Radiation Oncology (ASTRO).

Positive long-term outcomes after adjuvant accelerated partial breast irradiation

By

Long-term outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation after breast-conserving surgery show excellent tumor control with minimal late toxicity.

Brachytherapy raises future mastectomy risk compared with standard radiation in older women

By

When comparing treatments designed to enable long-term breast preservation for older women with invasive breast cancer, researchers found that those treated with brachytherapy were at higher risk for a later mastectomy.

Survival higher with brachytherapy for cervical cancer but use declines in US

By

Brachytherapy treatment was found to be associated with better cause-specific survival and overall survival in women with cervical cancer in a new study.

ASTRO: Cisplatin with RT and HDRB beneficial for cervical cancer

ASTRO: Cisplatin with RT and HDRB beneficial for cervical cancer

or women with stage IIIB squamous cervical cancer, cisplatin added to radiotherapy plus high-dose-rate brachytherapy (HDRB) is associated with improved disease-free survival.

APBI: What is it and who is the appropriate patient?

APBI: What is it and who is the appropriate patient?

Accelerated partial breast irradiation is an option for brachytherapy that can deliver higher doses with better cosmesis for select patients with breast cancer.

Study results support patient concerns about a controversial side effect of therapy

Study results support patient concerns about a controversial side effect of therapy

By

A posttreatment assessment of men who underwent treatment for prostate cancer revealed a side effect that has a significant impact on patients.

Older breast cancer patients have more complications with brachytherapy

By

The breast cancer treatment brachytherapy, heralded for its low complication rates, actually results in more complications than whole-breast radiation 1 year after treatment.

Genetic markers predict sexual problems after prostate radiation

Researchers have identified 12 genetic markers linked with susceptibility for erectile dysfunction after radiotherapy for prostate cancer.

Brachytherapy can be successful for high-risk prostate cases, too

By

Although brachytherapy has not been considered very effective for high-risk prostate cancer, it reduced disease-specific mortality compared with external beam radiation alone.

Proton therapy effective against prostate cancer

By

Two studies published in International Journal of Radiation Oncology*Biology*Physics indicate that proton therapy is a useful treatment for prostate cancer.

Brachytherapy may be overused in breast cancer patients

Many women who underwent accelerated partial breast irradiation using brachytherapy were deemed cautionary or unsuitable for the procedure based on guidelines later issued by ASTRO.

Brachytherapy doubled risk for mastectomy, complications in older women

Although popular among older women with breast cancer, accelerated partial breast brachytherapy may be less effective and more toxic than standard whole breast irradiation in these patients.

Updates from ASCO 2010: Radiotherapy and APBI

Data presented on the evolving role of radiation therapy in local and regional tumor control at the ASCO 2010 Breast Cancer Symposium, October 1-3, 2010, are reviewed.

Radiation dose after brachytherapy implant linked to prostate cancer treatment

By

Prostate cancer patients who receive the optimum radiation dose on the same day as their brachytherapy implant may have a lower risk of relapse, according to a study conducted by researchers at the University Hospital of Navarre.

Radiotherapy in the treatment of prostate cancer: Accuracy and effectiveness have improved

Modern radiotherapy achieves cure rates comparable to surgery for early stage prostate cancer and with androgen deprivation therapy, is the optimal treatment for transcasular extension of disease

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs